Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
A Pivotal Study to Evaluate the Safety and Effectiveness of Exablate Model 4000 Using Microbubble Resonators to Temporarily Mediate Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
Sponsor: InSightec
This NA trial investigates Glioblastoma and Glioma and is currently completed. InSightec leads this study, which shows 19 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
19 versions recorded-
Aug 2025 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2025 — Aug 2025 [monthly]
Recruiting NA
-
Nov 2024 — Jan 2025 [monthly]
Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 14 earlier versions
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
-
May 2024 — Jun 2024 [monthly]
Recruiting NA
-
Feb 2024 — May 2024 [monthly]
Recruiting NA
-
Dec 2023 — Feb 2024 [monthly]
Recruiting NA
-
Oct 2023 — Dec 2023 [monthly]
Recruiting NA
-
Sep 2023 — Oct 2023 [monthly]
Recruiting NA
-
Aug 2023 — Sep 2023 [monthly]
Recruiting NA
-
Jul 2023 — Aug 2023 [monthly]
Recruiting NA
-
Jun 2023 — Jul 2023 [monthly]
Recruiting NA
-
May 2023 — Jun 2023 [monthly]
Recruiting NA
-
Feb 2023 — May 2023 [monthly]
Recruiting NA
-
Nov 2022 — Feb 2023 [monthly]
Recruiting NA
-
Sep 2022 — Nov 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- InSightec
For direct contact, visit the study record on ClinicalTrials.gov .